Amylyx Pharmaceuticals, Inc. AMLX
Analyst Consensus
Price Objectif
Analyst historical
| Analyst | Entreprise | Price during analysis | Target price | Potential gain | Publication date |
|---|---|---|---|---|---|
| Seamus Fernandez | Guggenheim | 11.85 $ | 25 $ | 13.15 % | 15/09/2025 |
| Seamus Fernandez | Guggenheim | 6.41 $ | 17 $ | 10.59 % | 24/06/2025 |
| Marc Goodman | Leerink Partners | 4.65 $ | 10 $ | 5.35 % | 06/05/2025 |
| Joel Beatty | Robert W. Baird | 4.76 $ | 11 $ | 6.24 % | 18/11/2024 |
| Geoff Meacham | Bank of America Securities | 4.53 $ | 10 $ | 5.47 % | 23/10/2024 |
| Andrew Fein | H.C. Wainwright | 3.92 $ | 8 $ | 4.08 % | 18/10/2024 |
| Marc Goodman | Leerink Partners | 3.92 $ | 4 $ | 0.08 % | 18/10/2024 |
| Graig Suvannavejh | Mizuho Securities | 1.82 $ | 3 $ | 1.18 % | 14/05/2024 |
| Joel Beatty | Robert W. Baird | 2.46 $ | 3 $ | 0.54 % | 11/04/2024 |
| Neena Bitritto-Garg | Deutsche Bank | 2.615 $ | 4 $ | 1.39 % | 04/04/2024 |
| Graig Suvannavejh | Mizuho Securities | 3.24 $ | 4 $ | 0.76 % | 17/03/2024 |